{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:54:02Z","timestamp":1781636042098,"version":"3.54.5"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>In cardiac surgery, intraoperative tranexamic acid (TXA) is commonly used and highly recommended approach for managing perioperative bleeding. Nevertheless, a standardized dose and administration protocol remains undefined. This study compares the efficacy of intraoperative triple-dose intravenous (IV) bolus TXA versus IV bolus followed by continuous IV infusion in preventing postoperative bleeding in patients undergoing isolated coronary artery bypass grafting (CABG).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      The study included 93 patients who underwent elective isolated CABG between August 14, 2023, and October 14, 2024. Patients received either triple-dose IV bolus TXA (Group 1,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200953) or IV bolus followed by continuous IV infusion (Group 2,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200940) during surgery.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Postoperative bleeding was lower in Group 1 at all assessed time points (1\u00a0h: 116 vs. 146 mL; 6\u00a0h: 253 vs. 332 mL; 24\u00a0h: 589 vs. 713 mL). However, a statistically significant difference was found only at 6\u00a0h (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.03), representing an approximately 24% relative reduction in bleeding volume compared with Group 2. No significant differences were observed in transfusion requirements (packed red blood cells\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.85; fresh frozen plasma\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.55). Three patients in Group 2 required reoperation due to bleeding (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.07), and one late mortality occurred in Group 2 (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.43).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study suggests that triple-dose IV bolus TXA administration may be both an effective and safe strategy for preventing postoperative bleeding in isolated CABG surgery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>The study was registered at the Clinical Trial Registry (NCT05994989, August 8, 2023) on.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13019-026-03877-5","type":"journal-article","created":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:15:05Z","timestamp":1770884105000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Triple-dose bolus versus continuous infusion of tranexamic acid: impacts on clinical outcomes in isolated coronary artery bypass surgery"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5968-4561","authenticated-orcid":false,"given":"Osman","family":"Uzundere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5186-0586","authenticated-orcid":false,"given":"Mahmut","family":"Yarg\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2758-220X","authenticated-orcid":false,"given":"Selen","family":"Topalel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4459-001X","authenticated-orcid":false,"given":"Ahmet Serkan","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8970-3359","authenticated-orcid":false,"given":"Meral Erdal","family":"Erbatur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1524-8685","authenticated-orcid":false,"given":"H\u00fclya Tosun","family":"S\u00f6ner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2277-1020","authenticated-orcid":false,"given":"Re\u015fit","family":"Saruhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0015-948X","authenticated-orcid":false,"given":"Cem K\u0131v\u0131lc\u0131m","family":"Ka\u00e7ar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4945-9328","authenticated-orcid":false,"given":"Erhan","family":"G\u00f6k\u00e7ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,12]]},"reference":[{"issue":"17","key":"3877_CR1","doi-asserted-by":"publisher","first-page":"e021481","DOI":"10.1161\/JAHA.121.021361","volume":"10","author":"SS Dani","year":"2021","unstructured":"Dani SS, Minhas AMK, Arshad A, Krupica T, Goel SS, Virani SS, et al. Trends in characteristics and outcomes of hospitalized young patients undergoing coronary artery bypass grafting in the united States, 2004 to 2018. J Am Heart Assoc. 2021;10(17):e021481.","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"3877_CR2","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.21037\/jtd.2018.02.43","volume":"10","author":"L Melly","year":"2018","unstructured":"Melly L, Torregrossa G, Lee T, Jansens JL, Puskas JD. Fifty years of coronary artery bypass grafting. J Thorac Dis. 2018;10(3):1960\u20137.","journal-title":"J Thorac Dis"},{"issue":"6","key":"3877_CR3","first-page":"795","volume":"72","author":"MJ Colomina","year":"2022","unstructured":"Colomina MJ, Contreras L, Guilabert P, Koo M, M\u00e9ndez E, Sabate A. Clinical use of tranexamic acid: evidences and controversies. Braz J Anesthesiol. 2022;72(6):795\u2013812.","journal-title":"Braz J Anesthesiol"},{"issue":"11","key":"3877_CR4","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1053\/j.jvca.2019.04.003","volume":"33","author":"J Raphael","year":"2019","unstructured":"Raphael J, Mazer CD, Subramani S, Schroeder A, Abdalla M, Ferreira R, et al. Society of cardiovascular anesthesiologists clinical practice improvement advisory for management of perioperative bleeding and hemostasis in cardiac surgery patients. J Cardiothorac Vasc Anesth. 2019;33(11):2887\u201399.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"3877_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinane.2022.110654","volume":"78","author":"A Klein","year":"2022","unstructured":"Klein A, Agarwal S, Cholley B, Fassl J, Griffin M, Kaakinen T, et al. A review of European guidelines for patient blood management with a particular emphasis on antifibrinolytic drug administration for cardiac surgery. J Clin Anesth. 2022;78:110654.","journal-title":"J Clin Anesth"},{"key":"3877_CR6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1053\/j.jvca.2017.06.026","volume":"32","author":"C Boer","year":"2018","unstructured":"Boer C, Meesters MI, Milojevic M, Benedetto U, Bolliger D, von Heymann C, et al. 2017 EACTS\/EACTA guidelines on patient blood management for adult cardiac surgery. J Cardiothorac Vasc Anesth. 2018;32:88\u2013120.","journal-title":"J Cardiothorac Vasc Anesth"},{"issue":"5","key":"3877_CR7","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezae352","volume":"67","author":"FPA Casselman","year":"2025","unstructured":"Casselman FPA, Lance MD, Ahmed A, Ascari A, Blanco-Morillo J, Bolliger D, et al. 2024 EACTS\/EACTAIC guidelines on patient blood management in adult cardiac surgery in collaboration with EBCP. Eur J Cardiothorac Surg. 2025;67(5):ezae352. https:\/\/doi.org\/10.1093\/ejcts\/ezae352.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"1","key":"3877_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12959-021-00303-9","volume":"19","author":"A Ockerman","year":"2021","unstructured":"Ockerman A, Vanassche T, Garip M, Vandenbriele C, Engelen MM, Martens J, et al. Tranexamic acid for the prevention and treatment of bleeding in surgery, trauma and bleeding disorders: a narrative review. Thromb J. 2021;19(1):1\u201316.","journal-title":"Thromb J"},{"issue":"1","key":"3877_CR9","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/SLA.0000000000003793","volume":"273","author":"M Heyns","year":"2021","unstructured":"Heyns M, Knight P, Steve AK, Yeung JK. A single preoperative dose of tranexamic acid reduces perioperative blood loss: a meta-analysis. Ann Surg. 2021;273(1):75\u201381.","journal-title":"Ann Surg"},{"issue":"2","key":"3877_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1177\/021849230401200208","volume":"12","author":"S Chauhan","year":"2004","unstructured":"Chauhan S, Bisoi A, Kumar N, Mittal D, Kale S, Kiran U, et al. Dose comparison of tranexamic acid in pediatric cardiac surgery. Asian Cardiovasc Thorac Ann. 2004;12(2):121\u20134.","journal-title":"Asian Cardiovasc Thorac Ann"},{"issue":"3","key":"3877_CR11","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1093\/icvts\/ivv134","volume":"21","author":"S Hodgson","year":"2015","unstructured":"Hodgson S, Larvin JT, Dearman C. What dose of tranexamic acid is most effective and safe for adult patients undergoing cardiac surgery? Interact Cardiovasc Thorac Surg. 2015;21(3):384\u20138.","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"2","key":"3877_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1097\/ALN.0000000000003633","volume":"134","author":"PJ Zufferey","year":"2021","unstructured":"Zufferey PJ, Lanoisel\u00e9e J, Graouch B, Vieille B, Delavenne X, Ollier E. Exposure-response relationship of tranexamic acid in cardiac surgery: a model-based meta-analysis. Anesthesiology. 2021;134(2):165\u201378.","journal-title":"Anesthesiology"},{"issue":"10","key":"3877_CR13","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.1053\/j.jvca.2020.03.040","volume":"34","author":"V Besser","year":"2020","unstructured":"Besser V, Albert A, Sixt SU, Ackerstaff S, Roussel E, Ullrich S, et al. Fibrinolysis and the influence of tranexamic acid dosing in cardiac surgery. J Cardiothorac Vasc Anesth. 2020;34(10):2664\u201373.","journal-title":"J Cardiothorac Vasc Anesth"},{"key":"3877_CR14","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.ahj.2019.09.010","volume":"222","author":"J Shi","year":"2020","unstructured":"Shi J, Zhou C, Liu S, Sun H, Wang Y, Yan F, et al. Outcome impact of different tranexamic acid regimens in cardiac surgery with cardiopulmonary bypass (OPTIMAL): rationale, design, and study protocol of a multicenter randomized controlled trial. Am Heart J. 2020;222:147\u201356.","journal-title":"Am Heart J"},{"issue":"6","key":"3877_CR15","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1213\/ANE.0000000000002422","volume":"125","author":"J Spence","year":"2017","unstructured":"Spence J, Long S, Tidy A, Raymer K, Devereaux PJ, Lamy A, et al. Tranexamic acid administration during on-pump cardiac surgery: a survey of current practices among Canadian anesthetists working in academic centers. Anesth Analg. 2017;125(6):1863\u201370.","journal-title":"Anesth Analg"},{"issue":"3","key":"3877_CR16","doi-asserted-by":"publisher","first-page":"339","DOI":"10.4103\/aca.ACA_162_20","volume":"24","author":"T Madathil","year":"2021","unstructured":"Madathil T, Balachandran R, Kottayil B, Sundaram K, Nair S. Comparison of efficacy of two different doses of tranexamic acid in prevention of post operative blood loss in patients with congenital cyanotic heart disease undergoing cardiac surgery. Ann Card Anaesth. 2021;24(3):339\u201344.","journal-title":"Ann Card Anaesth"},{"key":"3877_CR17","unstructured":"American Heart Association. Classes and Stages of Heart Failure. Available from: https:\/\/www.heart.org\/en\/health-topics\/heart-failure\/what-is-heart-failure\/classes-of-heart-failure. [Accessed 10 Jun 2024]."},{"key":"3877_CR18","unstructured":"EuroSCORE II Calculator. Available from: https:\/\/www.euroscore.org\/index.php?id=17. [Accessed 10 Jun 2024]."},{"issue":"2","key":"3877_CR19","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jtcvs.2018.09.113","volume":"157","author":"PS Myles","year":"2019","unstructured":"Myles PS, Smith JA, Kasza J, Silbert B, Jayarajah M, Painter T, et al. Tranexamic acid in coronary artery surgery: One-year results of the aspirin and Tranexamic acid for coronary artery surgery (ATACAS) trial. J Thorac Cardiovasc Surg. 2019;157(2):644\u2013. \u2013\u200952.e9.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"1","key":"3877_CR20","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.bja.2019.08.028","volume":"124","author":"F Monaco","year":"2020","unstructured":"Monaco F, Nardelli P, Pasin L, Barucco G, Mattioli C, Di Tomasso N, et al. Tranexamic acid in open aortic aneurysm surgery: a randomised clinical trial. Br J Anaesth. 2020;124(1):35\u201343.","journal-title":"Br J Anaesth"},{"issue":"3","key":"3877_CR21","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.athoracsur.2021.03.033","volume":"112","author":"P Tibi","year":"2021","unstructured":"Tibi P, McClure RS, Huang J, Baker RA, Fitzgerald D, Mazer CD, et al. STS\/SCA\/AmSECT\/SABM update to the clinical practice guidelines on patient blood management. Ann Thorac Surg. 2021;112(3):981\u20131004.","journal-title":"Ann Thorac Surg"},{"issue":"6","key":"3877_CR22","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/j.bja.2024.03.023","volume":"132","author":"R Yoshii","year":"2024","unstructured":"Yoshii R, Takahashi Y, Tanaka KA, et al. Point-of-care testing for Tranexamic acid efficacy: a proof-of-concept study in cardiac surgical patients. Br J Anaesth. 2024;132(6):1211\u20138.","journal-title":"Br J Anaesth"},{"issue":"1","key":"3877_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12871-019-0772-0","volume":"19","author":"J Guo","year":"2019","unstructured":"Guo J, Gao X, Ma Y, Lv H, Hu W, Zhang S, et al. Different dose regimes and administration methods of tranexamic acid in cardiac surgery: a meta-analysis of randomized trials. BMC Anesthesiol. 2019;19(1):1\u201316.","journal-title":"BMC Anesthesiol"},{"issue":"5","key":"3877_CR24","doi-asserted-by":"publisher","first-page":"585","DOI":"10.2165\/11209070-000000000-00000","volume":"72","author":"PL McCormack","year":"2012","unstructured":"McCormack PL. Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis. Drugs. 2012;72(5):585\u2013617.","journal-title":"Drugs"},{"issue":"6","key":"3877_CR25","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/S1010-7940(05)80093-4","volume":"8","author":"G Valen","year":"1994","unstructured":"Valen G, Eriksson E, Risberg B, Vaage J. Fibrinolysis during cardiac surgery. Release of tissue plasminogen activator in arterial and coronary sinus blood. Eur J Cardiothorac Surg. 1994;8(6):324\u201330.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"3","key":"3877_CR26","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1097\/ALN.0000000000001997","volume":"128","author":"JH Levy","year":"2018","unstructured":"Levy JH, Koster A, Quinones QJ, Milling TJ, Key NS. Antifibrinolytic therapy and perioperative considerations. Anesthesiology. 2018;128(3):657\u201370.","journal-title":"Anesthesiology"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-026-03877-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-03877-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-026-03877-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T18:08:24Z","timestamp":1781633304000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13019-026-03877-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,12]]},"references-count":26,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3877"],"URL":"https:\/\/doi.org\/10.1186\/s13019-026-03877-5","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,12]]},"assertion":[{"value":"20 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This prospective observational study was conducted at Diyarbak\u0131r Gazi Ya\u015fargil Education and Research Hospital between August 14, 2023, and October 14, 2024. The trial was registered with ClinicalTrials.gov (NCT05994989, August 8, 2023). The study adhered to the principles of the 2013 Declaration of Helsinki.\u00a0The trial protocol was first approved by the ethics committee of SB\u00dc Diyarbak\u0131r Gazi Ya\u015fargil Training and Research Hospital\/Diyarbak\u0131r\/Turkey (date 08\/05\/2023, approval number 408). Simultaneously registered on\n                      \n                      (principal investigator: Osman Uzundere, MD; date of registration: 08 August 2023).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"136"}}